What was the overall valuation of the UK prebiotics market in 2024?

The overall market valuation was $158.86 Million in 2024. Read More

What is the projected market valuation for the UK prebiotics market by 2035?

The projected valuation for 2035 is $498.22 Million. Read More

What is the expected CAGR for the UK prebiotics market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 10.95%. Read More

Which companies are considered key players in the UK prebiotics market?

Key players include DuPont (US), Bifodan (DK), Kerry Group (IE), and others. Read More

What are the main sources of prebiotics in the UK market?

The main sources include Plant-based ($60.0 - $180.0 Million), Animal-based ($40.0 - $120.0 Million), and Microbial-derived ($58.86 - $198.22 Million). Read More

What forms of prebiotics are available in the UK market?

Available forms include Powder ($30.0 - $90.0 Million), Liquid ($40.0 - $120.0 Million), Capsules ($50.0 - $150.0 Million), and Tablets ($38.86 - $138.22 Million). Read More

What applications are driving the UK prebiotics market?

Driving applications include Functional Foods ($30.0 - $95.0 Million), Dietary Supplements ($40.0 - $130.0 Million), and Nutraceuticals ($50.0 - $160.0 Million). Read More

What end-use sectors are prominent in the UK prebiotics market?

Prominent end-use sectors include Food and Beverage ($70.0 - $220.0 Million), Pharmaceuticals ($50.0 - $160.0 Million), and Personal Care ($38.86 - $118.22 Million). Read More

How does the UK prebiotics market compare to other regions?

While specific regional comparisons are not provided, the UK market is poised for growth with a projected valuation increase by 2035. Read More

What trends are influencing the growth of the UK prebiotics market?

Trends include increasing consumer awareness of gut health and the rising demand for functional foods and dietary supplements. Read More

UK Prebiotics Market

UK Prebiotics Market Size, Share, Industry Trend & Analysis Research Report: By Type (Functional food & beverage, Dietary supplements, Others) and By Application (Fructooligosaccharides, Galactooligosaccharides, Inulin, Others) - Forecast to 2035.

Forecast Period

2025 - 2035

CAGR

10.95%

2024 Market Size

$ 158.86 Million

2035 Market Size

$ 498.22 Million

Food, Beverages & Nutrition ● Updated August 2026 Report ID: MRFR/FnB/56186-HCR | Pages: 200 | Author: Snehal Singh

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Source (USD Million)
  1. 4.1.1 Plant-based
  2. 4.1.2 Animal-based
  3. 4.1.3 Microbial-derived
2. 4.2 Pharmaceutical, BY Form (USD Million)
  1. 4.2.1 Powder
  2. 4.2.2 Liquid
  3. 4.2.3 Capsules
  4. 4.2.4 Tablets
3. 4.3 Pharmaceutical, BY Application (USD Million)
  1. 4.3.1 Functional Foods
  2. 4.3.2 Dietary Supplements
  3. 4.3.3 Nutraceuticals
  4. 4.3.4 Animal Feed
4. 4.4 Pharmaceutical, BY End Use (USD Million)
  1. 4.4.1 Food and Beverage
  2. 4.4.2 Pharmaceuticals
  3. 4.4.3 Personal Care
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 DuPont (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bifodan (DK)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Kerry Group (IE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Ginkgo BioWorks (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Nutraceutical International Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 ProbioFerm (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Synlogic (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Bifidobacterium (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY SOURCE
3. 6.3 UK MARKET ANALYSIS BY FORM
4. 6.4 UK MARKET ANALYSIS BY APPLICATION
5. 6.5 UK MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY SOURCE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY SOURCE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SOURCE, 2025-2035 (USD Million)
  2. 7.2.2 BY FORM, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Prebiotics Market Segmentation

UK Prebiotics Market By Source (USD Million, 2025-2035)

Plant-based
Animal-based
Microbial-derived

UK Prebiotics Market By Form (USD Million, 2025-2035)

Powder
Liquid
Capsules
Tablets

UK Prebiotics Market By Application (USD Million, 2025-2035)

Functional Foods
Dietary Supplements
Nutraceuticals
Animal Feed

UK Prebiotics Market By End Use (USD Million, 2025-2035)

Food and Beverage
UK Prebiotics Markets
Personal Care

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”